Background
==========

Depression is a prevalent disorder that is often chronic, and which is associated with psycho-social and physical problems, as well as suicide \[[@b1-medscimonit-25-389]\]. The current treatment regimens used for the management of depression exhibit a number of adverse effects and negatively affect patient health \[[@b2-medscimonit-25-389]\]. As such, development of alternative therapeutics with higher efficacy and fewer adverse effects is urgently required \[[@b3-medscimonit-25-389]\]. The natural world has long been a source of extraordinary drugs used for the treatment of a wide array of deadly diseases such as cancer \[[@b4-medscimonit-25-389]\]. Among natural sources, plants have been used for the alleviation of human ailments since prehistoric times, and they have been used for curing many diseases, including depression \[[@b5-medscimonit-25-389]\]. Moreover, it is believed that herbal therapies that use edible plants for treatment of diabetes may prove beneficial owing to the negligible adverse effects associated with edible plants \[[@b6-medscimonit-25-389]\]. *Taraxacum officinale,* also known as the common dandelion, is an important medicinal herb belonging to the family *Asteraceae* \[[@b7-medscimonit-25-389]\]. A number of pharmacological activities have been attributed to this plant such as anti-inflammatory, anti-proliferative, and anti-oxidant effects \[[@b8-medscimonit-25-389]\]. It has been reported that *T. officinale* extract protects against lead-induced brain damage \[[@b9-medscimonit-25-389]\]. It has been also shown to exhibit hepatoprotective effects \[[@b10-medscimonit-25-389]\]. In a recent study, *T. officinale* has also been reported to show antidepressive effects \[[@b11-medscimonit-25-389],[@b12-medscimonit-25-389]\]. However, the antidepressive effects of *T. officinale* have not been thoroughly investigated and the mechanism is unclear. Here, we examined the antidepressive effects of hydromethanolic extract of *T. officinale* and unveiled the probable mechanism of action. We also tentatively identified the active constituents of the extract that could be potentially responsible for its antidepressive effects. We believe that *T. officinale* may prove to be a vital and safer source of antidepressive agents and thus be used in the management of depression.

Material and Methods
====================

Plant material and preparation of the extract
---------------------------------------------

The fresh leaves of *T. officinale* were harvested from natural habitats. These harvested leaves were subjected to washing followed by shade-drying. The dried leaves the converted to a fine powder. The hydromethanolic extract of the powder was prepared as described previously. The extracts were then stored at 4°C in a vacuum until used for experimentation.

Animals and treatment groups
----------------------------

ICR male mice about 3 weeks old and weighing around 27 g were procured from the Animal Facility of the Mental Diseases Prevention and Treatment Institute of the Chinese PLA, PLA 91^st^ Central Hospital, Jiaozuo 454000, China under approval by the Ethics Committee of the same institute (approval no. 897MDP/2018. The mice were housed separately and maintained under standard conditions with free accesses to food and water under a 12: 12 light/dark cycle. The mice were randomly grouped in 5 groups. Group 1 received distilled water without TST, Group II received distilled water plus TST, Group III received bupropion plus TST, Group IV received 50 mg/kg hydromethanolic extract plus TST, and Group V received 100 mg/kg hydromethanolic extract plus TST.

Tail suspension test (TST)
--------------------------

The TST was carried out as described in the literature with minor modifications. In brief, the mice were hung from the tail in a white box with their heads at least 30 cm from the bottom. The background noise was minimized and each mouse was kept in this position for 4 min. The mice were then sacrificed and the brains were isolated and stored at −80°C for further experimentation.

Determination of serum corticosterone level and brain dopamine (DOP), noradrenaline (NA), and adrenaline (ADR) levels
---------------------------------------------------------------------------------------------------------------------

The blood serum was harvested by high-speed centrifugation for 15 min. We used Assay Max corticosterone ELSIA kits (Assaypro) for determination of corticosterone levels following the manufacturer's guidelines. Next, 50 mg of the limbic area of the brain was extracted and homogenised and the NAD, DOP, and ADR levels were estimated using the 3-CAT ELSIA kit as per the manufacturer's guidelines.

cDNA synthesis and quantitative RT-PCR
--------------------------------------

The RNA was isolated from the tissues by Trizol reagent and then transcribed into cDNA using RevertAid cDNA synthesis kits. The expression of Mpk1 and Bdnf was determined by qRT-PCR, as described previously \[[@b13-medscimonit-25-389]\]. The relative quantification (ΔΔ-CT) method was used to quantitatively evaluate variations between the samples examined. The reaction was performed in a total volume of 20 μl, which included 10 μl of 2 SYBR Green Master Mix, 0.2 μM gene-specific primers, and 100 ng of template cDNA. The cycling conditions were 95°C for 20 s, followed by 40 cycles of 95°C for 15 s and 58°C for 1 min. GAPDH was used as an endogenous control to normalize all data.

Phytochemical analysis
----------------------

The phytochemical analysis of the hydromethanolic extract of *T. officinale* was carried out as described previously \[[@b14-medscimonit-25-389]\]. In brief, the sample was prepared by dissolving it in methanol followed by filtration through a 0.22-μM nylon HPLC filter. The LC-MS apparatus of Nexera UHPLC (130 MPa) equipped with MS-8030 (Shimadzu) was used for the study, and data were generated using Lab Solutions software. The Enable RP-C18 column (250×4.6 mm, 5 μM) was used. The injection volume was 5 μL and flow rate was 0.3 ml/min. Mobile phase A (water and acetonitrile ratio 1: 1) and mobile phase B (0.1% Acetic acid in water) were used in a linear gradient flow and the column temperature was set at 75°C initially. Nitrogen was used as the interface gas and MS was obtained under the following MS parameters: positive and negative ionization modes, scan range 100--1000 m/z, ESI MS source, DL temperature 250°C, nebulising gas flow 3 L/min, heat block temperature 400°C, and drying gas flow of 15 L/min.

Statistical analysis
--------------------

The experiments were performed in triplicate and the data are expressed as mean ±SD. The Tukey's test followed by one-way ANOVA was used for statistical analysis using GraphPad prism 7 software. A *p* value of \>0.05 was considered statistically significant.

Results
=======

*T. officinale* hydromethanolic extract affects the immobility time in TST in mice
----------------------------------------------------------------------------------

The antidepressant activity of the hydromethanolic extract of *T. officinale* was evaluated by TST-triggered stress in mice. It was found that the administration of the extract at the dosage of 50 and 10 mg/kg had no apparent effects on weight or hair color. Moreover, no deaths were observed following admiration of the extract. The immobility time remained constant in all the groups up to day 4. However, from the day 5, the immobility time in Group II (the Model group that received TST stress) increased significantly. In contrast, the extract significantly reduced the TST-induced immobility. The effect of the extract at 100 mg/kg (Group V) on the immobility was comparable to that of the positive control bupropion-treated mice (Group III) ([Figure 1](#f1-medscimonit-25-389){ref-type="fig"})

*T. officinale* hydromethanolic extract affects the corticosterone levels in mice
---------------------------------------------------------------------------------

The serum corticosterone levels of the TST-stressed Group II significantly increased relative to the Group I receiving distilled water. However, administration of the extract at the dosages of 50 mg/kg (group IV) and 100 mg/kg (Group V) resulted in considerable decline in the corticosterone levels, which was similar to that of the Bupropion-treated group (Group III) ([Figure 2](#f2-medscimonit-25-389){ref-type="fig"}).

*T. officinale* hydromethanolic extract affects the DOP, ADR, and NAD levels in mice
------------------------------------------------------------------------------------

We found that the TST stress induced in Group II decreased the levels of DOP, ADR, and NAD in comparison to the vehicle group I. However, administration of the extract at 50 mg/kg and 100 mg/kg (Group IV and V) significantly restored the levels of DOP, ADR, and NAD. The effects of the positive control bupropion (Group III) were less than that of extract at the dosage of 100 mg/k g([Figure 3A--3C](#f3-medscimonit-25-389){ref-type="fig"}).

*T. officinale* hydromethanolic extract affects the expression of Mkp-1 and Bdnf in mice
----------------------------------------------------------------------------------------

The results revealed that TST stress (Group II) caused a significant increase in the expression of Mkp-1 in the limbic system, which was associated with decreased expression levels of Bdnf in comparison to the control group (Group I). However, administration of the extract at the dosage of 50 mg/kg and 100 mg/kg (Group IV and V) reversed the effects of TST stress on the expression of Mkp-1 and Bdnf. We found that extract at both these doses decreased the expression of Mkp-1 and increased the expression of Bdnf, but was lower than in the positive control bupropion group ([Figure 4A, 4B](#f4-medscimonit-25-389){ref-type="fig"}).

Phytochemical analysis of the hydromethanolic extract of *T. officinale*
------------------------------------------------------------------------

To identify the phytochemical constituents of the hydromethanolic extract of the hydromethanolic extract of *T. officinale,* LC/MS analysis was carried out. Several of the constituents were identified in a literature search. The main compounds identified from the extract were isoetin, hesperidin, naringenin, Kaempferol, sinapinic, and gallic acid ([Figure 5](#f5-medscimonit-25-389){ref-type="fig"}).

Discussion
==========

With advancements in the field of pharmacology, new drugs are being developed for treatment of diseases and disorders such as depression. However, even the newer antidepressants exhibit severe adverse effects on the overall health of the patients, which include elevated risk to heart attack, insomnia, and headache \[[@b16-medscimonit-25-389]\]. Depression is now becoming a huge threat to quality of life and is the second major cause of disease-related disability \[[@b17-medscimonit-25-389]\]. Because it has relatively fewer and less severe adverse effects, herbal medicine may prove beneficial in the treatment of depression. *T. officinale* is an important medicinal herb and has been reported to exhibit antidepressant effects \[[@b11-medscimonit-25-389],[@b12-medscimonit-25-389]\]. However, the antidepressant effects of this plant are not fully explored and its mechanism of action is not known. Herein, the antidepressant effects of the hydromethanolic extract of *T. officinale* was confirmed by TST, showing that the extract can significantly alleviate the TST-induced immobility and the effects were comparable to the positive control bupropion which is an antidepressant. It has been reported that stresses such as the TST in mice results in human depression-like condition and initiates corticosterone production, which ultimately causes a chain of endocrine events \[[@b18-medscimonit-25-389]\]. Here, we for the first time report that the hydromethanolic extract of *T. officinale* exerts antidepressant effects by decreasing corticosterone levels and by increasing the ADR, NAD, and DOP levels. In addition, the hydromethanolic extract of the *T. officinale* can increase the expression of the Brain-derived neurotrophic factor (Bdnf), which is associated with decreased expression of mitogen-activated protein kinase phosphatase-1 (Mkp-1). The increase in the expression of Bdnf and decrease in the expression of Mkp-1 has been reported to exert protective effects in TST-stressed mice, further complementing our findings \[[@b19-medscimonit-25-389]\]. Finally, the active constituents that are potentially responsible for the antidepressant effects of the *T. officinale* were identified: isoetin, hesperidin, naringenin, Kaempferol, sinapic, and gallic acid. Previous studies have also reported the presence of these compounds in *T. officinale* or other related species \[[@b20-medscimonit-25-389],[@b21-medscimonit-25-389]\]. Some of these metabolites have even been shown to exhibit antidepressant effects.

Conclusions
===========

The hydromethanolic extract of *T. officinale* exerts antidepressant effects in a mouse models of depression, mainly due to inhibition of corticosterone production, activation of DOP, ADA, and NAD production, and modulation of Bdnf and Mapk1 expression. Hence, *T. officinale* may prove beneficial in the management of depression.
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![(**A**) Effect of *T. officinale* extract on immobility time (seconds) for 7 days. (**B**) The immobility time of different groups on the final day. The experiments were performed in triplicate (\* p\<0.05).](medscimonit-25-389-g001){#f1-medscimonit-25-389}
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![Phytochemical profiling of *T. officinale* extract by LC/MS. The peaks represent the tentative identified compounds Peak 1: gallic acid, Peak 2: sinapinic acid, Peak 3: Naringenin, Peak 4: Kaempferol, Peak 5: Isotein, Peak 6: hesperidin.](medscimonit-25-389-g005){#f5-medscimonit-25-389}
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